Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

Home >
Life Sciences >
Pharmaceutical >
Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

Report price : $ 3 300
Publication date : November 2008

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market.

This Kalorama Information report, Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends) takes a thorough look at the emerging markets in these countries:

Egypt

United Arab Emirates

Isreal

Saudi Arabia

Jordan

As part of its exhuastive coverage, for each country's market, the report includes:

Current Pharmaceutical Market Size

Market Forecast

Regulatory Environment

Economic Statistics

Disease and Health Spending Statistics

Leading Pharmaceutical Suppliers
In addition, trends that apply to all countries such as generic competition, regulatory matters, Companies profiled in this report include:

Banaja

Dar Al Dawa

GlaxoSmithKline Egypt

Gulf Pharmaceutical Industries

Hikma Pharmaceuticals

Medical Union Pharmaceutical Company

Perrigo Israel

Pharco Pharmaceuticals

Saudi Pharmaceutical Industries and Medical Appliances Corp.

TEVA

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 30 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

TABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARY

Overview
Scope and Methodology
Size and Growth of the Market
Key Issues and Trends Affecting the Market
Leading Competitors

CHAPTER TWO: INTRODUCTION

Overview
Intellectual Property Rights and Compulsory Licensing
Biosimilar Production
World Health
Tobacco Use
Obesity

CHAPTER THREE: PHARMACEUTICAL MARKETS IN ISRAEL

Overview and Summary
Regulatory Environment
Intellectual Property Rights
Economic Development
GDP and Healthcare Spending
Healthcare Trends in Israel
Demographics
- Birth Rates
- Life Expectancy
- Mortality
Key Product Segments and Market Indicators
- Cardiovascular Disease
- Infection Control Disease
- Central Nervous System Drugs
- Oncology
Market Analysis
Sales of Pharmaceuticals by Generic Supply
Leading Pharmaceutical Suppliers

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN EGYPT

Overview and Summary
Regulatory Environment
Economic Development
GDP and Healthcare Spending
Healthcare Trends in Egypt
Demographics
Birth Rates
Life Expectancy
Mortality
Key Product Segments and Market Indicators
Cardiovascular Disease
Infection Control
Oncology
Diabetes
Market Analysis
Sales of Pharmaceuticals by Generic Supply
Leading Pharmaceutical Suppliers

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN SAUDI ARABIA

Overview and Summary
Regulatory Environment
Intellectual Property Rights
Economic Development
GDP and Healthcare Spending
Healthcare Trends in Saudi Arabia
Demographics
Birth Rates
Life Expectancy
Mortality
Key Product Segments and Market Indicators
Cardiovascular Disease
Infection Control
Oncology
Diabetes and Other Diseases
Market Analysis
Sales of Pharmaceuticals by Generic Supply
Leading Pharmaceutical Suppliers

CHAPTER SIX: PHARMACEUTICAL MARKETS IN JORDAN

Overview and Summary
Regulatory Environment
Intellectual Property Rights
Economic Development
GDP and Healthcare Spending
Healthcare Trends in Jordan
Jordanian Insurance Coverage
Demographics
Birth Rates
Life Expectancy
Mortality
Key Product Segments and Market Indicators
Cardiovascular Disease
Infection Control
Oncology
Diabetes
Market Analysis
Sales of Pharmaceuticals by Generic Supply
Leading Pharmaceutical Suppliers

CHAPTER SEVEN: PHARMACEUTICAL MARKETS IN THE UNITED ARAB EMIRATES

Overview and Summary
Regulatory Environment
Intellectual Property Rights
Economic Development
GDP and Healthcare Spending
Healthcare Trends in the UAE
Demographics
Birth Rates
Life Expectancy
Mortality
Key Product Segments and Market Indicators
Cardiovascular Disease
Infection Control
Oncology
Diabetes
Market Analysis
Sales of Pharmaceuticals by Generic Supply
Leading Pharmaceutical Suppliers

CHAPTER SEVEN: MARKET SUMMARY

Overview

CHAPTER EIGHT: LEADING PHARMACEUTICAL PROVIDERS IN THE MIDDLE EAST

Overview
Banaja
Dar Al Dawa
GlaxoSmithKline Egypt
Gulf Pharmaceutical Industries (Julphar)
Hikma Pharmaceuticals
Medical Union Pharmaceutical Company
Perrigo Israel
Pharco Pharmaceuticals
Saudi Pharmaceutical Industries & Medical Appliances Corporation
TEVA

APPENDIX: LIST OF MAJOR COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Figure 1-1: Middle East Market Analysis: 2005-201

CHAPTER THREE: PHARMACEUTICAL MARKETS IN ISRAEL

Table 3-1: Israel’s Economic Sectors
Table 3-2: Israel’s GDP and Healthcare Spending
Table 3-3: Israel - Midyear Population, by Age and Sex, 2007 and 2012
Figure 3-1: Israel - Midyear Population, by Age, 2007 and 2012
Table 3-4: Israel Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015
Figure 3-2: Israel Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015
Table 3-5: Israel Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020
Figure 3-3: Israel Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020
Table 3-6: Israel Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015
Figure 3-4: Israel Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015
Table 3-7: Tuberculosis Surveillance and Epidemiology, Israel
Table 3-8: Israel Pharmaceutical Market Analysis, 2005-2007
Table 3-9: Israel Pharmaceutical Market Analysis: 2008-2012
Figure 3-5: Israel Pharmaceutical Market Analysis: 2005-2012
Table 3-10: Estimated Sales of Pharmaceuticals in Israel by Generic Or Brand, 2007
Figure 3-6: Estimated Sales of Pharmaceuticals in Israel by Generic Or Brand, 2007

CHAPTER FOUR: PHARMACEUTICAL MARKETS IN EGYPT

Table 4-1: Egypt’s Economic Sectors
Table 4-2: Egypt’s GDP and Healthcare Spending
Table 4-3: Egypt - Midyear Population, by Age and Sex, 2007 and 2012
Figure 4-1: Egypt - Midyear Population, by Age, 2007 and 2012
Table 4-4: Egypt Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015
Figure 4-2: Egypt Fertility Rates and Births, Estimated 2000, 2005; Projected 2010, 2015
Table 4-5: Egypt Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020
Figure 4-3: Egypt Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020
Table 4-6: Egypt Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015
Figure 4-4: Egypt Mortality Rates and Numbers: Estimated 2000, 2005; Projected 2010, 2015
Table 4-7: Tuberculosis Surveillance and Epidemiology, Egypt
Table 4-8: Egypt Pharmaceutical Market Analysis, 2005-2007
Table 4-9: Egypt Pharmaceutical Market Analysis: 2008-2012
Figure 4-5: Egypt Pharmaceutical Market Analysis: 2005-2012
Table 4-10: Estimated Sales of Pharmaceuticals in Egypt by Generic Or Brand, 2007
Figure 4-6: Estimated Sales of Pharmaceuticals in Egypt by Generic Or Brand, 2007

CHAPTER FIVE: PHARMACEUTICAL MARKETS IN SAUDI ARABIA

Table 5-1: Saudi Arabia’s Economic Sectors
Table 5-2: Saudi Arabia’s GDP and Healthcare Spending
Table 5-3: Saudi Arabia - Midyear Population, by Age and Sex, 2007 and 2012
Figure 5-1: Saudi Arabia - Midyear Population, by Age, 2007 and 2012
Table 5-4, Saudi Arabia Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015
Figure 5-2: Saudi Arabia Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015
Table 5-5: Saudi Arabia Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020
Figure 5-3: Saudi Arabia Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020
Table 5-6: Saudi Arabia Mortality Rates and Numbers, Estimated 2000, 2005; Projected 2010, 2015
Figure 5-4: Saudi Arabia Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015
Table 5-7: Tuberculosis Surveillance and Epidemiology, Saudi Arabia
Table 5-8: Saudi Arabia Cancer Incidence in Men and Women 2006
Table 5-9: Saudi Arabia Pharmaceutical Market Analysis, 2005-2007
Table 5-10: Saudi Arabia Pharmaceutical Market Analysis: 2008-2012
Figure 5-4: Saudi Arabia Pharmaceutical Market Analysis: 2005-2012
Table 5-11: Estimated Sales of Pharmaceuticals in Saudi Arabia by Generic Or Brand, 2007
Figure 5-5: Estimated Sales of Pharmaceuticals in Saudi Arabia by Generic Or Brand, 2007

CHAPTER SIX: PHARMACEUTICAL MARKETS IN JORDAN

Table 6-1: Jordan’s Economic Sectors
Table 6-2: Jordan’s GDP and Healthcare Spending
Table 6-3: Jordan - Midyear Population, by Age and Sex, 2007 and 2012
Figure 6-1: Jordan - Midyear Population, by Age, 2007 and 2012
Table 6-4: Jordan Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015
Figure 6-2: Jordan Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015
Table 6-5: Jordan Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020
Figure 6-3L Jordan Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020
Table 6-6: Jordan Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015
Figure 6-4: Jordan Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015
Table 6-7: Tuberculosis Surveillance and Epidemiology, Jordan
Table 6-8: Jordan Pharmaceutical Market Analysis, 2005-2007
Table 6-9: Jordan Pharmaceutical Market Analysis: 2008-2012
Figure 6-5: Jordan Pharmaceutical Market Analysis: 2005-2012
Table 6-10: Estimated Sales of Pharmaceuticals in Jordan by Generic Or Brand, 2007
Figure 6-6: Estimated Sales of Pharmaceuticals in Jordan by Generic Or Brand, 2007

CHAPTER SEVEN: PHARMACEUTICAL MARKETS IN THE UNITED ARAB EMIRATES

Table 7-1: United Arab Emirates’ Economic Sectors
Table 7-2: United Arab Emirates’ GDP and Healthcare Spending
Table 7-3: UAE - Midyear Population, by Age and Sex, 2007 and 2012
Figure 7-1: UAE - Midyear Population, by Age, 2007 and 2012
Table 7-4: UAE Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015
Figure 7-2: UAE Fertility Rates and Births - Estimated 2000, 2005; Projected 2010, 2015
Table 7-5: UAE Life Expectancy at Birth, 2000, 2005; Projections, 2010, 2015 and 2020
Figure 7-3: UAE Life Expectancy at Birth by Sex, 2000, 2005; Projections 2010, 2015 and 2020
Table 7-6: UAE Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015
Figure 7-4: UAE Mortality Rates and Numbers - Estimated 2000, 2005; Projected 2010, 2015
Table 7-7: UAE Pharmaceutical Market Analysis, 2005-2007
Table 7-8: UAE Pharmaceutical Market Analysis: 2008-2012
Figure 7-5: UAE Pharmaceutical Market Analysis: 2005-2012
Table 7-9: Estimated Sales of Pharmaceuticals in UAE by Generic Supply, 2007
Figure 7-6: Estimated Sales of Pharmaceuticals in UAE by Generic Or Brand, 2007

CHAPTER EIGHT: MARKET SUMMARY

Table 8-1: Pharmaceutical Markets in the Middle East: Market Analysis, 2005-2007
Table 8-2: Pharmaceutical Markets in the Middle East: Market Analysis: 2008-2012
Figure 8-1: Pharmaceutical Markets in the Middle East: Market Analysis: 2005-2012
Table 8-3: Middle East Pharmaceutical Markets by Country, 2007
Figure 8-2: Middle East Pharmaceutical Markets by Country, 2007

RELATED REPORTS

Smoking Cessation: World Markets

$ 3 500
November 2008

Smoking cessation is among the most dynamic pharmaceutical markets, and one that is expected to grow despite economic conditions. More than 5 million deaths are attributed to nicotine each year. This has encouraged public health entities to pursue smoking cessation, and has driven development of smo ...

Industries : Pharmaceutical

Protein Therapeutics Markets (Antithrobins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments)

$ 3 495
December 2008

The substances utilized for what is commonly referred to as 'protein therapeutics' have one thing in common --- they are all composed primarily of á-amino acids; and these á-amino acids are linked together by a distinct chemical bond known as a “peptide” bond. Used in a variety of areas of med ...

Industries : Pharmaceutical

Non-pharmacy OTC market in Poland 2008

$ 2 000
April 2008

Non-pharmacy OTC market in Poland 2008 - Development forecasts for 2008-2010 presents a comprehensive assessment of the market for OTC preparations and products sold in non-pharmacy retail businesses from 2005 to 2010 (in the case of drugs 2002-2010).The report discusses the market value and provide ...

Industries : Pharmaceutical, Over-The-Counter Drug

Clinical Trials in Poland 2008-Development forecasts for 2008-2010

$ 2 750
June 2008

Clinical trials in Poland 2008 is the second edition of our research of the sector and thus it offers you a unique opportunity to keep track of market trends and developments over the last several years. It provides a comprehensive study of the sector, with data on its value and development prospect ...

Industries : Pharmaceutical

OTC market in Central and Eastern Europe 2008

$ 2 625
August 2008

OTC market in Central and Eastern Europe 2008 offers a detailed discussion of the OTC sector, with special attention given to its most important markets: Russia, Poland, Romania, Hungary, Ukraine, the Czech Republic, Bulgaria and Slovakia. The report is an indispensable guide for those considering e ...

Industries : Pharmaceutical, Over-The-Counter Drug

The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)

$ 2 500
November 2008

Dominated by Lab Corp and Quest, the clinical laboratory services market is growing as new competitors enter. An essential part of the health industry, it is estimated that approximately 80% of physician’s diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical la ...

Industries : Pharmaceutical

Sleep Aid Products in the U.S. Market: Non-Prescription OTC, Natural and Alternative Remedies

$ 3 300
December 2008

Sleep has finally emerged from the darkness and gained the limelight as a critical American health issue. According to the American Sleep Association, every year approximately 40 million Americans, if not more, are afflicted by chronic, long-term sleep disorders. Restless nights followed by sluggish ...

Industries : Pharmaceutical

Japanese Pharmaceutical Market 2008-2023

$ 2 501
October 2008
123 pages

Last year, the Japanese pharmaceutical market was the second largest in the world, with a value of $58.5bn. However, Japan’s market has experienced growth at a much lower rate than the other major pharmaceutical markets. It is at a key stage in its development. You need to take notice of these cha ...

Industries : Pharmaceutical

Women`s Reproductive Disorders Therapeutics 2008-2018

$ 2 501
September 2008
100 pages

Oral Contraceptive MarketThe systemic hormonal contraceptive market is currently a $7bn market, with hormonal oral contraceptives dominating the market for many years. The oral pills are increasingly facing competition from other routes of delivery. With patent expiration, several companies have beg ...

Industries : Pharmaceutical

Global Antivirals Market Analysis & Forecasts 2008-2023

$ 2 501
September 2008
145 pages

Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from the inception of focused antiviral drug research, there are 8 blockbuster drugs currently on the market. Its double-digit ...

Industries : Pharmaceutical

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE) - get our PDF brochure

24/7 Customer Service

Contact Shadi now !

(866) 682 9815
Ask Shadi by email

Related industries

Pharmaceutical Industry

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.